Last checked at 26 Sep 2017 07:00
Silver Falcon Plc
(to become Hemogenyx Pharmaceuticals Plc)
Investor presentations
Silver Falcon Plc, (LSE: SILF), which has agreed to acquire the biotechnology company Hemogenyx Pharmaceuticals Limited ("Hemogenyx"), announces that it will be holding a series of meetings with investors regarding the opportunity presented to shareholders by the proposed acquisition of Hemogenyx LLC ("Hemogenyx").
The presentation will be led by Chief Executive Officer & Co-Founder of Hemogenyx, Dr Vladislav Sandler, with other Proposed Directors available for discussions after the formal presentation. The same presentation will be given at all events which are being held at different times to offer convenient options for those wishing to attend.
3 October 2017 - Lunchtime presentation hosted by Peterhouse Corporate Finance Limited
Time: | 12.30pm - a sandwich lunch will be provided |
Location: | 3rd Floor New Liverpool House, 15 Eldon Street, London EC2M 7LD |
3 October 2017 - Afternoon Presentation hosted by Shard Capital Partners LLP
Time: | 5pm - the presentation will be followed by drinks and canapes |
Location: | 23rd Floor, 20 Fenchurch Street, London EC3M 3BY |
4 October 2017 - Evening presentation hosted by Optiva Securities Limited
Time: | 6pm - the presentation will be followed by drinks and canapes |
Location: | Sartoria, 20 Savile Row, London W1S 3PR |
For more information on the proposed acquisition see the Latest News section on: www.silverfalconplc.com
For a short video by Dr Sandler on Hemogenyx click here: www.brrmedia.co.uk/event/160159
If you would like to register for any of the investor presentations, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email hemogenyx@walbrookpr.com ensuring you detail in your email which presentation you would like to attend.
Hemogenyx Pharmaceuticals Limited | www.hemogenyx.com | |
Peter Redmond, Director | Via Walbrook PR | |
|
| |
Optiva Securities Ltd | Tel: +44 (0)20 3137 1902 | |
Christian Dennis |
| |
|
| |
Shard Capital Partners LLP | Tel: +44 (0)20 7186 9950 | |
Damon Heath, Erik Woolgar |
| |
|
| |
Peterhouse Corporate Finance Limited | Tel: +44 (0)20 7469 0930 | |
Lucy Williams/Duncan Vasey |
| |
|
| |
Walbrook PR | Tel: +44 (0)20 7933 8780 or hemogenyx@walbrookpr.com | |
Paul McManus | Mob: +44 (0)7980 541 893 | |
|
| |
Flowcomms IR | Mob: +44 (0)7891 627 441 or sasha@flowcomms.com | |
Sasha Sethi |
| |